Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs
TF Luscher, M Barton - Circulation, 2000 - Am Heart Assoc
The 21-amino acid peptide endothelin-1 (ET-1) is the predominant isoform of the endothelin
peptide family, which includes ET-2, ET-3, and ET-4. It exerts various biological effects …
peptide family, which includes ET-2, ET-3, and ET-4. It exerts various biological effects …
Endothelins in cardiovascular biology and therapeutics
N Dhaun, DJ Webb - Nature Reviews Cardiology, 2019 - nature.com
Cardiovascular disease is a major contributor to global morbidity and mortality and is the
common end point of many chronic diseases. The endothelins comprise three structurally …
common end point of many chronic diseases. The endothelins comprise three structurally …
The clinical potential of endothelin receptor antagonists in cardiovascular medicine
CJ Ferro, DJ Webb - Drugs, 1996 - Springer
The endothelin family of peptides are extremely potent endogenous vasoconstrictor and
pressor agents. Of the 3 isoforms, endothelin-1 is the major isoform produced by the …
pressor agents. Of the 3 isoforms, endothelin-1 is the major isoform produced by the …
Cardiovascular endothelins: essential regulators of cardiovascular homeostasis
F Brunner, C Brás-Silva, AS Cerdeira… - Pharmacology & …, 2006 - Elsevier
The endothelin (ET) system consists of 3 ET isopeptides, several isoforms of activating
peptidases, and 2 G-protein-coupled receptors, ETA and ETB, that are linked to multiple …
peptidases, and 2 G-protein-coupled receptors, ETA and ETB, that are linked to multiple …
Endothelins in health and disease
R Shah - European journal of internal medicine, 2007 - Elsevier
Endothelins are powerful vasoconstrictor peptides that also play numerous other roles. The
endothelin (ET) family consists of three peptides produced by a variety of tissues. Endothelin …
endothelin (ET) family consists of three peptides produced by a variety of tissues. Endothelin …
The endothelin system and its potential as a therapeutic target in cardiovascular disease
Endothelin (ET)-1, an endothelium-derived peptide, is the most potent vasoconstrictor agent
described to date. ET-1 also has positive inotropic and chronotropic effects in the heart and …
described to date. ET-1 also has positive inotropic and chronotropic effects in the heart and …
Endothelin and endothelin antagonists: pharmacology and clinical implications.
TF Lüscher, RR Wenzel - Agents and actions. Supplements, 1995 - europepmc.org
Endothelins (ET) are a family of peptides with potent biological properties. Endothelial cells
produce exclusively ET-1 while other tissues produce ET-2 and ET-3. The production of ET …
produce exclusively ET-1 while other tissues produce ET-2 and ET-3. The production of ET …
Role of endothelin in the cardiovascular system
F Rodríguez-Pascual, O Busnadiego, D Lagares… - Pharmacological …, 2011 - Elsevier
The endothelin (ET) system consists of three peptide ligands (ET-1, ET-2 and ET-3) and two
G-protein-coupled receptors, ETA and ETB. In the cardiovascular system, ETs, particularly …
G-protein-coupled receptors, ETA and ETB. In the cardiovascular system, ETs, particularly …
Endothelin receptor antagonists
S Motte, K McEntee, R Naeije - Pharmacology & therapeutics, 2006 - Elsevier
Endothelin receptor antagonists (ERAs) have been developed to block the effects of
endothelin-1 (ET-1) in a variety of cardiovascular conditions. ET-1 is a powerful …
endothelin-1 (ET-1) in a variety of cardiovascular conditions. ET-1 is a powerful …
The importance of endothelin-1 for vascular dysfunction in cardiovascular disease
F Böhm, J Pernow - Cardiovascular research, 2007 - academic.oup.com
Abstract Endothelin (ET)-1 is a potent vasoconstrictor peptide originally isolated from
endothelial cells. Its production is stimulated in a variety of different cell types under the …
endothelial cells. Its production is stimulated in a variety of different cell types under the …